These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
244 related items for PubMed ID: 2458447
1. Effect of depletion of brain serotonin by repeated fenfluramine on neurochemical and anorectic effects of acute fenfluramine. Kleven MS, Schuster CR, Seiden LS. J Pharmacol Exp Ther; 1988 Sep; 246(3):822-8. PubMed ID: 2458447 [Abstract] [Full Text] [Related]
2. Possible involvement of endogenous opiates in the tolerance to the anorectic effect of fenfluramine. Groppetti A, Parenti M, Dellavedova L, Tirone F. J Pharmacol Exp Ther; 1984 Feb; 228(2):446-53. PubMed ID: 6694120 [Abstract] [Full Text] [Related]
3. Effects of repeated fenfluramine administration on indices of monoamine function in rat brain: pharmacokinetic, dose response, regional specificity and time course data. Zaczek R, Battaglia G, Culp S, Appel NM, Contrera JF, De Souza EB. J Pharmacol Exp Ther; 1990 Apr; 253(1):104-12. PubMed ID: 2329498 [Abstract] [Full Text] [Related]
4. Fenfluramine and 5-hydroxytryptamine. Part 2: Involvement of brain 5-hydroxytryptamine in the anorectic activity of fenfluramine. Duhault J, Boulanger M, Voisin C, Malen C, Schmitt H. Arzneimittelforschung; 1975 Nov; 25(11):1758-62. PubMed ID: 128366 [Abstract] [Full Text] [Related]
5. Neurotoxic effects of +/-fenfluramine and phenteramine, alone and in combination, on monoamine neurons in the mouse brain. McCann UD, Yuan J, Ricaurte GA. Synapse; 1998 Nov; 30(3):239-46. PubMed ID: 9776127 [Abstract] [Full Text] [Related]
6. In vivo correlates of central serotonin function after high-dose fenfluramine administration. Baumann MH, Ayestas MA, Rothman RB. Ann N Y Acad Sci; 1998 May 30; 844():138-52. PubMed ID: 9668672 [Abstract] [Full Text] [Related]
7. The effect of depletion of brain dopamine by 6-hydroxydopamine on tolerance to the anorexic effect of d-amphetamine and fenfluramine in rats. Heffner TG, Seiden LS. J Pharmacol Exp Ther; 1979 Jan 30; 208(1):134-43. PubMed ID: 759608 [Abstract] [Full Text] [Related]
8. Fenfluramine selectively and differentially decreases the density of serotonergic nerve terminals in rat brain: evidence from immunocytochemical studies. Appel NM, Contrera JF, De Souza EB. J Pharmacol Exp Ther; 1989 Jun 30; 249(3):928-43. PubMed ID: 2732954 [Abstract] [Full Text] [Related]
9. Effects of high-dose fenfluramine treatment on monoamine uptake sites in rat brain: assessment using quantitative autoradiography. Appel NM, Mitchell WM, Contrera JF, De Souza EB. Synapse; 1990 Jun 30; 6(1):33-44. PubMed ID: 2144664 [Abstract] [Full Text] [Related]
10. Effects of subchronic exposure to styrene on the extracellular and tissue levels of dopamine, serotonin and their metabolites in rat brain. Gagnaire F, Chalansonnet M, Carabin N, Micillino JC. Arch Toxicol; 2006 Oct 30; 80(10):703-12. PubMed ID: 16518643 [Abstract] [Full Text] [Related]
11. Fenfluramine and norfenfluramine levels in brain microdialysate, brain tissue and plasma of rats administered doses of d-fenfluramine known to deplete 5-hydroxytryptamine levels in brain. Clausing P, Newport GD, Bowyer JF. J Pharmacol Exp Ther; 1998 Feb 30; 284(2):618-24. PubMed ID: 9454806 [Abstract] [Full Text] [Related]
12. Effects of antihistamines on fenfluramine-induced depletion of indoles in the brain of rats. Yeh SY. Synapse; 1999 Jun 15; 32(4):301-11. PubMed ID: 10332805 [Abstract] [Full Text] [Related]
13. Differential effects of d-fenfluramine and p-chloroamphetamine on H75/12-induced depletion of 5-hydroxytryptamine and dopamine in the rat brain. Fattaccini CM, Gozlan H, Hamon M. Neuropharmacology; 1991 Jan 15; 30(1):15-23. PubMed ID: 1710793 [Abstract] [Full Text] [Related]
14. Biochemical and histological evidence that methylenedioxymethylamphetamine (MDMA) is toxic to neurons in the rat brain. Commins DL, Vosmer G, Virus RM, Woolverton WL, Schuster CR, Seiden LS. J Pharmacol Exp Ther; 1987 Apr 15; 241(1):338-45. PubMed ID: 2883295 [Abstract] [Full Text] [Related]
15. D-, L- and DL-fenfluramine cause long-lasting depletions of serotonin in rat brain. Kleven MS, Seiden LS. Brain Res; 1989 Dec 29; 505(2):351-3. PubMed ID: 2598057 [Abstract] [Full Text] [Related]
16. High-dose fenfluramine administration decreases serotonin transporter binding, but not serotonin transporter protein levels, in rat forebrain. Rothman RB, Jayanthi S, Wang X, Dersch CM, Cadet JL, Prisinzano T, Rice KC, Baumann MH. Synapse; 2003 Dec 01; 50(3):233-9. PubMed ID: 14515341 [Abstract] [Full Text] [Related]
17. Effect of repeated ('binge') dosing of MDMA to rats housed at normal and high temperature on neurotoxic damage to cerebral 5-HT and dopamine neurones. Sanchez V, O'shea E, Saadat KS, Elliott JM, Colado MI, Green AR. J Psychopharmacol; 2004 Sep 01; 18(3):412-6. PubMed ID: 15358986 [Abstract] [Full Text] [Related]
18. Progress report on the anorectic effects of dexfenfluramine, fluoxetine and sertraline. Garattini S, Bizzi A, Caccia S, Mennini T. Int J Obes Relat Metab Disord; 1992 Dec 01; 16 Suppl 3():S43-50. PubMed ID: 1338321 [Abstract] [Full Text] [Related]
19. 3,4-methylenedioxymethamphetamine (MDMA) administration to rats decreases brain tissue serotonin but not serotonin transporter protein and glial fibrillary acidic protein. Wang X, Baumann MH, Xu H, Rothman RB. Synapse; 2004 Sep 15; 53(4):240-8. PubMed ID: 15266556 [Abstract] [Full Text] [Related]